Arlene D. Parsons

Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism

Arya Sobhakumari, Laurie Love-Homan, Elise V.M. Fletcher et al. · PLoS ONE · 2012 · 79 citations · Full text

Chemoprevention Strategy, Lipid Peroxidation, Pathology +19

Erlotinib-Mediated Inhibition of EGFR Signaling Induces Metabolic Oxidative Stress through NOX4

Kevin P. Orcutt, Arlene D. Parsons, Zita A. Sibenaller et al. · Cancer Research · 2011 · 78 citations · Full text

Reductive Stress, Redox Signaling, Oxidative Stress Parameters +13

Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism

David Mattson, Iman M. Ahmad, Disha Dayal et al. · Free Radical Biology and Medicine · 2008 · 60 citations · Full text

Medicine, Pharmacology, Human Head +9

Inhibition of Glutathione and Thioredoxin Metabolism Enhances Sensitivity to Perifosine in Head and Neck Cancer Cells

Andrean L. Simons, Arlene D. Parsons, Katherine A. Foster et al. · Journal of Oncology · 2009 · 39 citations · Full text

Reductive Stress, Neck Cancer Cells, Chemoprevention Strategy +14

2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells

Arya Sobhakumari, Kevin P. Orcutt, Laurie Love-Homan et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2016 · 22 citations · Full text

Tumor Biology, Oncology, Chemoprevention Strategy +13